Illumavista Biosciences LLC is categorized under Chemical Consultants in Madison, WI .
Illumavista Biosciences LLC was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Chemical Consultants business, which does work in the B2B market, and is classified as a Chemical Consultants, under code number 5416908 by the NAICS.
If you are seeking more information, feel free to contact Mary Ozers, Marketing at the company’s single location by writing to 505 South Rosa Road, Madison, Wisconsin WI 53719 or by phoning (608) 335-7294. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Illumavista Biosciences LLC |
| Contact Person: | Mary Ozers, Marketing |
| Address: | 505 South Rosa Road, Madison, Wisconsin 53719 |
| Phone Number: | (608) 335-7294 |
| Website Address: | illumavista.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Chemical Consultants |
| SIC Code: | 8999 |
| NAICS Code: | 5416908 |
| Share This Business: |
Illumavista Biosciences LLC was started in 0 to provide professional Chemical Consultants under the SIC code 8999 and NAICS code 5416908. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Mary Ozers, Marketing for inquiries that concern Illumavista Biosciences LLC by calling the company number (608) 335-7294, as your correspondence is most welcome. Additionally, the physical location of the single location of Illumavista Biosciences LLC can be found at the coordinates 43.05787,-89.47833 as well as the street address 505 South Rosa Road in Madison, Wisconsin 53719.
For its online presence, you may visit Illumavista Biosciences LLC’s website at illumavista.com and engage with its social media outlets through on Twitter and on Facebook.